Quantamental Technologies LLC Halozyme Therapeutics, Inc. Transaction History

Quantamental Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$37.35 - $48.3 $94,495 - $122,199	2,530 Added 31.56%	10,546 $464,000
Q1 2022 May 16, 2022	SELL	$31.97 - $41.06 $65,378 - $83,967	-2,045 Reduced 20.33%	8,016 $320,000
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $6,236 - $7,987	196 Added 1.99%	10,061 $405,000
Q3 2021 Nov 15, 2021	BUY	$38.47 - $46.42 $379,506 - $457,933	9,865 New	9,865 $401,000
Q4 2020 Feb 16, 2021	SELL	$25.81 - $43.62 $280,477 - $474,018	-10,867 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$25.74 - $29.63 $279,716 - $321,989	10,867 New	10,867 $286,000
Q4 2019 Feb 14, 2020	SELL	$14.93 - $19.53 $116,722 - $152,685	-7,818 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$15.2 - $17.69 $34,443 - $40,085	-2,266 Reduced 22.47%	7,818 $121,000
Q2 2019 Aug 12, 2019	BUY	$14.75 - $17.26 $148,739 - $174,049	10,084 New	10,084 $173,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.